<?xml version='1.0' encoding='utf-8'?>
<rss version="2.0">
	<channel>
		<title>OOIR Trends: Clinical Medicine (Pharmacology &amp; Pharmacy)</title>
		<description>Aktuelle Paper-Trends im Bereich Clinical Medicine (Pharmacology &amp; Pharmacy) von OOIR (mit Titel und Metadaten von Crossref)</description>
		<link>https://ooir.org</link>
		<language>en-us</language>
		<pubDate>Thu, 15 Jan 2026 01:10:35 GMT</pubDate>
		<lastBuildDate>Thu, 15 Jan 2026 01:10:35 GMT</lastBuildDate>
		<item>
			<title>Aspartame decreases fat deposits in mice at a cost of mild cardiac hypertrophy and reduced cognitive performance</title>
			<link>https://doi.org/10.1016/j.biopha.2025.118891</link>
			<description>Feld: Clinical Medicine
Kategorie: Pharmacology &amp; Pharmacy
Score: 253
Autoren: Irati Aiestaran-Zelaia, María Jesús Sánchez-Guisado, Marta Beraza, Libe López-Arandia, Sandra Plaza-García, Irene Fernández-Folgueral, Antonio de Molina-Iracheta, Ian J. Holt, Jesus Ruiz-Cabello
Journal: Biomedicine &amp;amp; Pharmacotherapy
Veröffentlicht: 2026-01-01
DOI: 10.1016/j.biopha.2025.118891
ISSN: 0753-3322
Tag der Erhebung (OOIR): 2026-01-15</description>
			<guid isPermaLink="false">ooir-trend-10.1016/j.biopha.2025.118891-2026-01-15-1</guid>
			<pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Selective anti-cancer effects of cannabidiol and Δ9-tetrahydrocannabinol via PI3K/AKT/mTOR inhibition and PTEN restoration in ovarian cancer cells</title>
			<link>https://doi.org/10.3389/fphar.2025.1693129</link>
			<description>Feld: Clinical Medicine
Kategorie: Pharmacology &amp; Pharmacy
Score: 160
Autoren: Siyao Tong, Watcharin Loilome, Nisana Namwat, Poramate Klanrit, Arporn Wangwiwatsin, Zar Zar Win, Preeya Koyabuth, Bandit Chumworathayi
Journal: Frontiers in Pharmacology
Veröffentlicht: 2025-12-15
Abstract: 
                    Introduction
                    Ovarian cancer is a highly lethal gynecological malignancy, often diagnosed at advanced stages. Cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) demonstrate anti-tumor activity in various cancers including ovarian cancer through multiple signaling pathways and are increasingly explored as adjuncts to chemotherapy. However, the effects of CBD and THC combination treatment and its specific mechanisms remain unclear. This study evaluated the anti-tumor effects of CBD, THC, and their combination on SKOV3 and A2780 ovarian cancer cells, focusing on phosphorylation-dependent regulation of the PI3K/AKT/mTOR pathway.
                  
                  
                    Methods
                    SKOV3, A2780, and IOSE cells were treated with CBD, THC, and equimolar CBD: THC combinations. Cytotoxicity was assessed using Sulforhodamine B assay, while synergistic interactions were analyzed by the Chou-Talay method using CompuSyn. Cell cycle distribution and apoptosis were evaluated, and phosphorylation of PI3K, AKT, mTOR, and PTEN was examined by Western blotting.
                  
                  
                    Results
                    
                      The CBD: THC combination treatment showed potent, selective cytotoxicity at 48 h, with lower IC
                      50
                      values than in non-tumor IOSE80 cells. The Chou–Talalay method validated a synergistic effect between CBD and THC. The combination treatment induced cell cycle arrest and enhanced apoptosis. Western blot analysis exhibited that equimolar CBD: THC (2.5:2.5 μM) markedly reduced phosphorylation of PI3K, AKT, and mTOR, while increasing phosphorylation of PTEN, thereby reactivating tumor-suppressive signaling.
                    
                  
                  
                    Conclusion
                    
                      These findings highlight that CBD: THC combination treatment effectively inhibited ovarian cancer cell growth and invasion via oncogenic PI3K/AKT/mTOR signaling and reactivates PTEN. The combination may represent a promising targeted therapeutic approach, warranting further
                      in vivo
                      validation to elucidate its clinical potential.
                    
                  
DOI: 10.3389/fphar.2025.1693129
ISSN: 1663-9812
Tag der Erhebung (OOIR): 2026-01-15</description>
			<guid isPermaLink="false">ooir-trend-10.3389/fphar.2025.1693129-2026-01-15-2</guid>
			<pubDate>Mon, 15 Dec 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>2025 FDA approvals</title>
			<link>https://doi.org/10.1038/d41573-026-00001-z</link>
			<description>Feld: Clinical Medicine
Kategorie: Pharmacology &amp; Pharmacy
Score: 123
Autoren: Asher Mullard
Journal: Nature Reviews Drug Discovery
Veröffentlicht: 2026-01-02
DOI: 10.1038/d41573-026-00001-z
ISSN: 1474-1776
Tag der Erhebung (OOIR): 2026-01-15</description>
			<guid isPermaLink="false">ooir-trend-10.1038/d41573-026-00001-z-2026-01-15-3</guid>
			<pubDate>Fri, 02 Jan 2026 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Advances and updates in antibiotic combination therapy</title>
			<link>https://doi.org/10.1080/14787210.2025.2595462</link>
			<description>Feld: Clinical Medicine
Kategorie: Pharmacology &amp; Pharmacy
Score: 93
Autoren: Claudia Bartalucci, Chiara Sepulcri, Federica Portunato, Federica Briano, Chiara Dentone, Matteo Bassetti
Journal: Expert Review of Anti-infective Therapy
Veröffentlicht: 2025-12-25
DOI: 10.1080/14787210.2025.2595462
ISSN: 1478-7210
Tag der Erhebung (OOIR): 2026-01-15</description>
			<guid isPermaLink="false">ooir-trend-10.1080/14787210.2025.2595462-2026-01-15-4</guid>
			<pubDate>Thu, 25 Dec 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Drugs anticipated to be selected for Medicare price negotiation in 2026 for implementation in 2028</title>
			<link>https://doi.org/10.18553/jmcp.2025.25253</link>
			<description>Feld: Clinical Medicine
Kategorie: Pharmacology &amp; Pharmacy
Score: 92
Autoren: Emma M. Cousin, Kristi Martin, Ryan N. Hansen, John Coster, Sean D. Sullivan
Journal: Journal of Managed Care &amp;amp; Specialty Pharmacy
Veröffentlicht: 2026-01-01
DOI: 10.18553/jmcp.2025.25253
ISSN: 2376-0540
Tag der Erhebung (OOIR): 2026-01-15</description>
			<guid isPermaLink="false">ooir-trend-10.18553/jmcp.2025.25253-2026-01-15-5</guid>
			<pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
		</item>
	</channel>
</rss>